Vaccination With the Pneumococcal Vaccine GSK 1024850A or Prevenar at Approximately 4 Years of Age in Children Primed With 3 Doses of GSK 1024850A Vaccine or Prevenar and Boosted With 23-valent Pneumococcal Plain Polysaccharide Vaccine [EXTENSION OF 700018341]

Trial Profile

Vaccination With the Pneumococcal Vaccine GSK 1024850A or Prevenar at Approximately 4 Years of Age in Children Primed With 3 Doses of GSK 1024850A Vaccine or Prevenar and Boosted With 23-valent Pneumococcal Plain Polysaccharide Vaccine [EXTENSION OF 700018341]

Completed
Phase of Trial: Phase III

Latest Information Update: 08 Jan 2017

At a glance

  • Drugs Pneumococcal 10-valent vaccine conjugate (Primary) ; Pneumococcal 7-valent CRM197 vaccine conjugate
  • Indications Streptococcal infections
  • Focus Pharmacodynamics
  • Sponsors GlaxoSmithKline
  • Most Recent Events

    • 11 Apr 2013 Integrated European Clinical Trials Database record.
    • 11 Apr 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top